Malaria parasites both repress host CXCL10 and use it as a cue for growth acceleration
-
Published:2021-08-11
Issue:1
Volume:12
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
Ofir-Birin YifatORCID, Ben Ami Pilo Hila, Cruz Camacho Abel, Rudik Ariel, Rivkin Anna, Revach Or-Yam, Nir Netta, Block Tamin Tal, Abou Karam Paula, Kiper Edo, Peleg Yoav, Nevo Reinat, Solomon Aryeh, Havkin-Solomon Tal, Rojas Alicia, Rotkopf RonORCID, Porat ZivORCID, Avni Dror, Schwartz Eli, Zillinger ThomasORCID, Hartmann GuntherORCID, Di Pizio AntonellaORCID, Quashie Neils BenORCID, Dikstein Rivka, Gerlic Motti, Torrecilhas Ana ClaudiaORCID, Levy Carmit, Nolte-‘t Hoen Esther N. M., Bowie Andrew G.ORCID, Regev-Rudzki NetaORCID
Abstract
AbstractPathogens are thought to use host molecular cues to control when to initiate life-cycle transitions, but these signals are mostly unknown, particularly for the parasitic disease malaria caused by Plasmodium falciparum. The chemokine CXCL10 is present at high levels in fatal cases of cerebral malaria patients, but is reduced in patients who survive and do not have complications. Here we show a Pf ‘decision-sensing-system’ controlled by CXCL10 concentration. High CXCL10 expression prompts P. falciparum to initiate a survival strategy via growth acceleration. Remarkably, P. falciparum inhibits CXCL10 synthesis in monocytes by disrupting the association of host ribosomes with CXCL10 transcripts. The underlying inhibition cascade involves RNA cargo delivery into monocytes that triggers RIG-I, which leads to HUR1 binding to an AU-rich domain of the CXCL10 3’UTR. These data indicate that when the parasite can no longer keep CXCL10 at low levels, it can exploit the chemokine as a cue to shift tactics and escape.
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference99 articles.
1. Rieke, B. Overview of the worldwide Handling with the Disease in Prevention, Diagnostics and Therapy WHO World Malaria Report 2017. Flugmed. Tropenme 25, 5–5 (2018). 2. Verlinden, B. K., Louw, A. & Birkholtz, L. M. Resisting resistance: is there a solution for malaria? Expert Opin. Drug Discov. 11, 395–406 (2016). 3. Dunst, J., Kamena, F. & Matuschewski, K. Cytokines and chemokines in cerebral malaria pathogenesis. Front. Cell. Infect. Microbiol 7, 324 (2017). 4. Jain, V. et al. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar. J. 7, 83 (2008). 5. Wilson, N. O. et al. CXCL4 and CXCL10 predict risk of fatal cerebral malaria. Dis. Markers 30, 39–49 (2011).
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|